Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Optimization of Vonoprazan-Amoxicillin Dual Therapy for H. pylori
NCT05719831Phase 3Completed
- Sponsor
- The Sixth Affiliated Hospital of Sun Yat-Sen University
- Start
- Feb 2023
- Primary completion
- Sep 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of vonoprazan in Helicobacter pylori infection (3 arms), sponsored by The Sixth Affiliated Hospital of Sun Yat-Sen University. Primary endpoint: H. pylori eradication rate at 6 weeks. Started Feb 2023; status: completed.
02
Drugs
vonoprazan
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on NCT05719831.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05719831.